Why the study?
Does exposure to aspirin or acetaminophen increase the risk of gastrointestinal bleeding in patients without predisposing diseases?
Does exposure to aspirin or acetaminophen increase the risk of gastrointestinal bleeding in patients without predisposing diseases?
Heavy regular aspirin use, but not light use or acetaminophen, is associated with an increased risk of serious gastrointestinal bleeding.
Answers are grounded in this paper and cite their sources.
May support caution with heavy aspirin dosing; leaves open need for randomized confirmation of dose thresholds and acetaminophen safety.
All patients observed in this analysis of the Boston Collaborative Drug Surveillance Program data had no known disease predisposing them to gastrointestinal (GI) bleeding. Major GI bleeding occurred in hospitalized patients recently exposed to ethacrynic acid (5/111; 4.5%), heparin sodium (7/575; 1.2%), corticosteroids (7/1,484; 0.5%), aspirin (6/2,081; 0.3%), and warfarin sodium (1/423; 0.2%); combinations of two or more of these drugs also resulted in substantial incidences of bleeding. The rates for minor GI bleeding in hospitalized patients varied from 8.3% for heparin to 1.6% for aspirin. In outpatients admitted because of serious GI bleeding, 14/88 (16%) had a history of heavy, regular aspirin use compared with 1,015/14,813 (6.9%) control subjects admitted for other reasons (relative risk, 2.1). No association between light regular use of aspirin and GI bleeding was noted. No association between the use of acetaminophen and GI bleeding was noted in any of the patients studied.
No takes yet. Share an insight, caveat, or question.
Hershel Jick (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: